LOUISVILLE, KY, USA – Hello, versatility. Advanced Solutions announces their newest patented, cGMP and UL certified bioprinter, the BioAssemblyBot® 200. BAB200, as its affectionately known, joins the award winning BioAssemblyBot® 400 (BAB400) as an automated multi-tasking bioprinter. BioAssemblyBot® 200 uses a four-axis robotic arm to bioprint and automate the science workflow.
“BAB200 provides our customers with a powerful benchtop alternative to develop and translate research ideas into clinical reality.” said Michael Golway, P.E., the Lead Inventor of the BioAssembly platform and CEO of Advanced Solutions.
BioAssemblyBot® 200 is built on the foundation of over 50,000+ hours of research and development that created the BioAssemblyBot® 400 platform. Innovations like interchangeable BioAssemblyTools™, vision tip detect, variable print stage, and the design/make software programs of TSIM® and BioApps™, respectively, are just a few of the features from the BAB400 platform that are now available in BAB200. Breaking the mold from other traditional bioprinters, BioAssemblyBot® 200 combines four-axis robotics with three unique forms to meet your needs. Whether in its enclosed form on the lab benchtop, enclosed with HEPA filtration system, or in a biosafety cabinet, BAB200 is a powerhouse at 3D biology efficiency and capability.
BioAssemblyBot® 200 is sleek and fits right in with your existing lab equipment. BAB200 is easy-to-use and control with the included touch screen interface.
“The BioAssemblyBot 200 is the most versatile bioprinter I have used in my 30+ years of work. My team readily transitions from HEPA-controlled prints on the benchtop to fully sterile work in a biosafety cabinet, performing a spectrum of different printing tasks with the same machine” said Dr. Jay Hoying, Chief Scientist of Advanced Solutions
BioAssemblyBot® 200 is more than a 3D bioprinter. With bays for up to five active BioAssemblyTools™, BAB200 offers flexibility in the bioprinting workflow to deliver a rich library of automated science outcomes ensuring a return on investment that will supercharge research results.